Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema

Auerbach, 1974, Relation of smoking and age to findings in lung parenchyma: a microscopic study, Chest, 65, 29, 10.1378/chest.65.1.29 Cottin, 2005, Combined pulmonary fibrosis and emphysema: a distinct under recognised entity, Eur. Respir. J., 26, 586, 10.1183/09031936.05.00021005 Portillo, 2012, Combined pulmonary fibrosis and emphysema syndrome: a new phenotype within the spectrum of smoking-related interstitial lung disease, Pulm Med, 2012, 10.1155/2012/867870 Jankowich, 2012, Combined pulmonary fibrosis and emphysema syndrome: a review, Chest, 141, 222, 10.1378/chest.11-1062 Cottin, 2013, The impact of emphysema in pulmonary fibrosis, Eur. Respir. Rev., 22, 153, 10.1183/09059180.00000813 Mejía, 2009, Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension, Chest, 136, 10, 10.1378/chest.08-2306 Tanabe, 2015, Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases, Respirology, 20, 805, 10.1111/resp.12530 Seeger, 2013, Pulmonary hypertension in chronic lung diseases, J. Am. Coll. Cardiol., 62, D109, 10.1016/j.jacc.2013.10.036 Nathan, 2019, Pulmonary hypertension in chronic lung disease and hypoxia, Eur. Respir. J., 53, 10.1183/13993003.01914-2018 Cottin, 2010, Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome, Eur. Respir. J., 35, 105, 10.1183/09031936.00038709 Lange, 2014, Outcome of patients with severe PH due to lung disease with and without targeted therapy, Cardiovasc Ther, 32, 202, 10.1111/1755-5922.12084 Ghio, 2017, Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension, Int. J. Cardiol., 230, 53, 10.1016/j.ijcard.2016.12.099 Hoeper, 2015, Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias, PLoS One, 10, 10.1371/journal.pone.0141911 Takimoto, 2005, Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy, Nat. Med., 11, 214, 10.1038/nm1175 Han, 2013, Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction, Chest, 143, 1699, 10.1378/chest.12-1594 Shimoda, 2013, Vascular remodeling in pulmonary hypertension, J. Mol. Med. (Berl.), 91, 297, 10.1007/s00109-013-0998-0